Join
Live feed
·
PRReleasevia Quantisnow
GlucoTrack Inc. logo

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

ByQuantisnow·Wall Street's wire, on your screen.
GCTK· GlucoTrack Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GCTK (GlucoTrack Inc.) and more on Quantisnow.